Atea Historical Balance Sheet

AVIR Stock

USD 3.82 0.21 5.82%

Trend analysis of Atea PharmaceuticalsInc balance sheet accounts such as Other Current Liab of 20.6 M, Total Current Liabilities of 57 M or Total Stockholder Equity of 434.1 M provides information on Atea PharmaceuticalsI's total assets, liabilities, and equity, which is the actual value of Atea PharmaceuticalsInc to its prevalent stockholders. By breaking down trends over time using Atea PharmaceuticalsI balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Atea PharmaceuticalsInc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Atea PharmaceuticalsInc is a good buy for the upcoming year.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

About Atea Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Atea PharmaceuticalsInc at a specified time, usually calculated after every quarter, six months, or one year. Atea PharmaceuticalsI Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Atea PharmaceuticalsI and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Atea currently owns. An asset can also be divided into two categories, current and non-current.

Atea PharmaceuticalsI Balance Sheet Chart

Atea PharmaceuticalsI Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Atea PharmaceuticalsInc uses and utilizes its capital. It also shows what exactly a company owns and owes.

At this time, Atea PharmaceuticalsI's Property Plant And Equipment Gross is relatively stable compared to the past year. As of 05/22/2024, Accumulated Other Comprehensive Income is likely to grow to about 217.3 K, while Other Current Liabilities is likely to drop slightly above 20.6 M.

Total Assets Other Current Liab Total Current Liabilities Other Liab Cash Liabilities And Stockholders Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Atea PharmaceuticalsI assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Atea PharmaceuticalsInc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Atea PharmaceuticalsI balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Atea PharmaceuticalsInc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Cash

Cash refers to the most liquid asset of Atea PharmaceuticalsInc, which is listed under current asset account on Atea PharmaceuticalsInc balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Atea PharmaceuticalsI customers. The amounts must be unrestricted with restricted cash listed in a different Atea PharmaceuticalsI account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Liabilities And Stockholders Equity

The total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation.

Most accounts from Atea PharmaceuticalsI's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Atea PharmaceuticalsInc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	52.3M	15.2M	27.4M	20.6M
Total Assets	772.9M	666.7M	595.0M	541.8M

Other Current Liab Total Assets

Atea PharmaceuticalsI balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Non Current Liabilities Other
Total Assets		0.82	0.69	0.98	0.73	0.96	0.55	-0.89	-0.24	0.69	0.89	0.58	0.57	0.4	1.0	0.97	0.85	-0.98	0.9	0.97	0.39	0.98	0.57	1.0	0.97	0.73
Other Current Liab	0.82		0.31	0.87	0.83	0.86	0.38	-0.69	-0.03	0.91	0.69	0.42	0.43	0.25	0.82	0.82	0.76	-0.81	0.72	0.82	0.01	0.87	0.41	0.82	0.83	0.8
Total Current Liabilities	0.69	0.31		0.53	0.06	0.5	0.01	-0.72	-0.11	0.01	0.72	0.01	0.02	-0.04	0.69	0.56	0.48	-0.61	0.39	0.53	0.94	0.53	0.01	0.69	0.56	0.06
Total Stockholder Equity	0.98	0.87	0.53		0.84	0.99	0.64	-0.85	-0.24	0.8	0.84	0.67	0.66	0.49	0.98	0.98	0.86	-0.98	0.94	0.99	0.2	1.0	0.65	0.98	0.99	0.83
Other Liab	0.73	0.83	0.06	0.84		0.84	0.8	-0.46	-0.43	0.93	0.45	0.83	0.84	0.4	0.73	0.79	0.76	-0.82	0.86	0.84	-0.29	0.84	0.83	0.73	0.83	1.0
Net Tangible Assets	0.96	0.86	0.5	0.99	0.84		0.66	-0.79	-0.3	0.84	0.79	0.68	0.68	0.44	0.96	0.99	0.85	-0.97	0.96	0.99	0.17	0.99	0.67	0.96	0.99	0.84
Property Plant And Equipment Net	0.55	0.38	0.01	0.64	0.8	0.66		-0.25	-0.69	0.61	0.25	1.0	0.99	0.54	0.55	0.64	0.59	-0.67	0.83	0.7	-0.28	0.64	1.0	0.55	0.68	0.84
Net Debt	-0.89	-0.69	-0.72	-0.85	-0.46	-0.79	-0.25		-0.19	-0.46	-1.0	-0.28	-0.24	-0.54	-0.89	-0.81	-0.69	0.81	-0.7	-0.79	-0.5	-0.85	-0.24	-0.89	-0.79	-0.43
Retained Earnings	-0.24	-0.03	-0.11	-0.24	-0.43	-0.3	-0.69	-0.19		-0.24	0.19	-0.68	-0.74	0.19	-0.23	-0.32	-0.34	0.38	-0.43	-0.37	0.01	-0.24	-0.72	-0.24	-0.37	-0.48
Accounts Payable	0.69	0.91	0.01	0.8	0.93	0.84	0.61	-0.46	-0.24		0.46	0.65	0.65	0.33	0.69	0.79	0.71	-0.73	0.79	0.8	-0.33	0.8	0.64	0.69	0.79	0.92
Cash	0.89	0.69	0.72	0.84	0.45	0.79	0.25	-1.0	0.19	0.46		0.27	0.23	0.54	0.89	0.81	0.68	-0.8	0.7	0.78	0.5	0.84	0.24	0.89	0.79	0.43
Non Current Assets Total	0.58	0.42	0.01	0.67	0.83	0.68	1.0	-0.28	-0.68	0.65	0.27		0.99	0.54	0.57	0.66	0.62	-0.69	0.85	0.73	-0.28	0.67	1.0	0.57	0.7	0.86
Non Currrent Assets Other	0.57	0.43	0.02	0.66	0.84	0.68	0.99	-0.24	-0.74	0.65	0.23	0.99		0.45	0.56	0.66	0.6	-0.69	0.83	0.72	-0.27	0.66	1.0	0.57	0.7	0.87
Other Assets	0.4	0.25	-0.04	0.49	0.4	0.44	0.54	-0.54	0.19	0.33	0.54	0.54	0.45		0.4	0.43	0.35	-0.38	0.58	0.45	-0.23	0.49	0.48	0.4	0.41	0.4
Cash And Short Term Investments	1.0	0.82	0.69	0.98	0.73	0.96	0.55	-0.89	-0.23	0.69	0.89	0.57	0.56	0.4		0.96	0.85	-0.98	0.89	0.97	0.39	0.98	0.56	1.0	0.97	0.72
Common Stock Total Equity	0.97	0.82	0.56	0.98	0.79	0.99	0.64	-0.81	-0.32	0.79	0.81	0.66	0.66	0.43	0.96		0.84	-0.97	0.96	0.99	0.23	0.98	0.65	0.96	1.0	0.79
Common Stock Shares Outstanding	0.85	0.76	0.48	0.86	0.76	0.85	0.59	-0.69	-0.34	0.71	0.68	0.62	0.6	0.35	0.85	0.84		-0.87	0.82	0.86	0.19	0.86	0.61	0.85	0.86	0.75
Non Current Liabilities Total	-0.98	-0.81	-0.61	-0.98	-0.82	-0.97	-0.67	0.81	0.38	-0.73	-0.8	-0.69	-0.69	-0.38	-0.98	-0.97	-0.87		-0.93	-0.98	-0.3	-0.98	-0.68	-0.98	-0.98	-0.81
Other Current Assets	0.9	0.72	0.39	0.94	0.86	0.96	0.83	-0.7	-0.43	0.79	0.7	0.85	0.83	0.58	0.89	0.96	0.82	-0.93		0.97	0.05	0.94	0.83	0.9	0.96	0.86
Other Stockholder Equity	0.97	0.82	0.53	0.99	0.84	0.99	0.7	-0.79	-0.37	0.8	0.78	0.73	0.72	0.45	0.97	0.99	0.86	-0.98	0.97		0.19	0.99	0.72	0.97	1.0	0.84
Total Liab	0.39	0.01	0.94	0.2	-0.29	0.17	-0.28	-0.5	0.01	-0.33	0.5	-0.28	-0.27	-0.23	0.39	0.23	0.19	-0.3	0.05	0.19		0.2	-0.27	0.39	0.23	-0.29
Net Invested Capital	0.98	0.87	0.53	1.0	0.84	0.99	0.64	-0.85	-0.24	0.8	0.84	0.67	0.66	0.49	0.98	0.98	0.86	-0.98	0.94	0.99	0.2		0.65	0.98	0.99	0.83
Property Plant And Equipment Gross	0.57	0.41	0.01	0.65	0.83	0.67	1.0	-0.24	-0.72	0.64	0.24	1.0	1.0	0.48	0.56	0.65	0.61	-0.68	0.83	0.72	-0.27	0.65		0.56	0.69	0.86
Total Current Assets	1.0	0.82	0.69	0.98	0.73	0.96	0.55	-0.89	-0.24	0.69	0.89	0.57	0.57	0.4	1.0	0.96	0.85	-0.98	0.9	0.97	0.39	0.98	0.56		0.97	0.72
Capital Stock	0.97	0.83	0.56	0.99	0.83	0.99	0.68	-0.79	-0.37	0.79	0.79	0.7	0.7	0.41	0.97	1.0	0.86	-0.98	0.96	1.0	0.23	0.99	0.69	0.97		0.82
Non Current Liabilities Other	0.73	0.8	0.06	0.83	1.0	0.84	0.84	-0.43	-0.48	0.92	0.43	0.86	0.87	0.4	0.72	0.79	0.75	-0.81	0.86	0.84	-0.29	0.83	0.86	0.72	0.82

Click cells to compare fundamentals

Atea PharmaceuticalsI Account Relationship Matchups

Atea PharmaceuticalsI balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	22.1M	863.6M	772.9M	666.7M	595.0M	541.8M
Other Current Liab	1.9M	14.4M	52.3M	15.2M	27.4M	20.6M
Total Current Liabilities	2.4M	315.8M	56.9M	18.5M	32.4M	57.0M
Total Stockholder Equity	(49.6M)	547.8M	710.1M	640.6M	555.2M	434.1M
Other Liab	95K	36K	5.9M	5.3M	6.0M	6.3M
Net Tangible Assets	(49.6M)	547.8M	710.1M	640.6M	736.7M	398.8M
Property Plant And Equipment Net	41K	48K	23K	4.1M	3.1M	3.3M
Net Debt	(21.7M)	(850.1M)	(764.2M)	(643.6M)	(141.4M)	(148.5M)
Retained Earnings	(54.2M)	(65.2M)	56.0M	(59.9M)	(195.8M)	(186.0M)
Accounts Payable	548K	60K	4.5M	2.6M	4.3M	2.3M
Cash	21.7M	850.1M	764.4M	646.7M	143.8M	136.6M
Cash And Short Term Investments	21.7M	850.1M	764.4M	646.7M	578.1M	530.8M
Common Stock Shares Outstanding	82.6M	82.4M	88.2M	83.2M	83.4M	85.7M
Liabilities And Stockholders Equity	22.1M	863.6M	772.9M	666.7M	595.0M	541.8M
Non Current Liabilities Total	69.2M	36K	5.9M	7.7M	7.4M	7.0M
Other Current Assets	249K	7.5M	8.0M	14.2M	12.3M	7.8M
Other Stockholder Equity	4.6M	612.9M	654.0M	701.1M	750.7M	500.0M
Total Liab	71.6M	315.8M	62.8M	26.1M	39.8M	78.3M
Net Invested Capital	(49.6M)	547.8M	710.1M	640.6M	555.2M	434.1M
Property Plant And Equipment Gross	41K	48K	184K	4.4M	3.8M	4.0M
Total Current Assets	21.9M	863.5M	772.4M	660.9M	590.5M	539.7M
Accumulated Other Comprehensive Income	(69.1M)	(863.6M)	0.0	(684K)	207K	217.4K
Net Working Capital	19.5M	547.7M	715.5M	642.4M	558.1M	461.3M
Property Plant Equipment	41K	48K	23K	4.1M	4.7M	4.9M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Atea PharmaceuticalsInc is a strong investment it is important to analyze Atea PharmaceuticalsI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Atea PharmaceuticalsI's future performance. For an informed investment choice regarding Atea Stock, refer to the following important reports:

How To Invest In Atea

Details

Is Atea Stock a good investment?

Details

What is Atea PharmaceuticalsI's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Atea Stock analysis

When running Atea PharmaceuticalsI's price analysis, check to measure Atea PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea PharmaceuticalsI is operating at the current time. Most of Atea PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Atea PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Atea PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.

	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Technical Analysis Check basic technical indicators and analysis based on most latest market data

Is Atea PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atea PharmaceuticalsI. If investors know Atea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atea PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

2.641

Earnings Share

(1.95)

Revenue Per Share

2.31

Quarterly Revenue Growth

2.952

Return On Assets

(0.16)

The market value of Atea PharmaceuticalsInc is measured differently than its book value, which is the value of Atea that is recorded on the company's balance sheet. Investors also form their own opinion of Atea PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Atea PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Atea PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Atea PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Atea PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Atea Historical Balance Sheet

About Atea Balance Sheet Analysis

Atea PharmaceuticalsI Balance Sheet Chart

Total Assets

Total Current Liabilities

Cash

Liabilities And Stockholders Equity

Atea PharmaceuticalsI balance sheet Correlations

Atea PharmaceuticalsI Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Atea PharmaceuticalsI balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Atea Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Non Current Liabilities Other	+ 1.0	Other Liab
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net

Cash	- 1.0	Net Debt
Capital Stock	- 0.98	Non Current Liabilities Total
Total Current Assets	- 0.98	Non Current Liabilities Total
Net Invested Capital	- 0.98	Non Current Liabilities Total
Other Stockholder Equity	- 0.98	Non Current Liabilities Total
Non Current Liabilities Total	- 0.98	Cash And Short Term Investments